When microbe meets human

Clinical Infectious Diseases

Volumn 39, Issue 6, 2004, Pages 827-830

  Reid, Gregor ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

BACTERIAL COLONIZATION; DIGESTION; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNITY; MATERNAL DISEASE; MICROORGANISM; NEWBORN DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VAGINA FLORA;

ANIMALS; BACTERIA; HUMANS; IMMUNITY; PROBIOTICS; SYMBIOSIS;

EID: 4544277023     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/423387     Document Type: Review

References (27)

1. Gibbons RJ, Hay DI, Childs WC 3rd, Davis G. Role of cryptic receptors (cryptitopes) in bacterial adhesion to oral surfaces. Arch Oral Biol 1990; 35(Suppl):107S-14S.
2. Ganz T. Epithelia: not just physical barriers. Proc Natl Acad Sci U S A 2002; 99:3357-8.
3. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002; 168:171-8.
4. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 2002; 99:15451-5.
5. Chi D, Yan G. From wired to wireless: a miniature robot for intestinal inspection. J Med Eng Technol 2003; 27:71-6.
6. Stebbings S, Munro K, Simon MA, et al. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology (Oxford) 2002; 41:1395-401.
7. Sayer AA. Are rates of ageing determined in utero? Age Ageing 1998; 27:579-83.
8. Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003; 23:297-302.
9. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361:1869-71.
10. Akdis M, Trautmann A, Klunker S, et al. T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J 2003; 17:1026-35.
11. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347:911-20.
12. Weiss ST. Eat dirt - the hygiene hypothesis and allergic diseases. N Engl J Med 2002; 347: 930-1.
13. Saran S, Gopalan S, Krishna TP. Use of fermented foods to combat stunting and failure to thrive. Nutrition 2002; 18:393-6.
14. Carter JA, Neville BG, Newton CR. Neurocognitive impairment following acquired central nervous system infections in childhood: a systematic review. Brain Res Brain Res Rev 2003; 43:57-69.
15. Schell MA, Karmirantzou M, Snel B, et al. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci U S A 2002; 99:14422-7.
16. Sperandio V, Torres AG, Jarvis B, et al. Bacteria-host communication: the language of hormones. Proc Natl Acad Sci U S A 2003; 100:8951-6.
17. Shanahan F. Immunology. Therapeutic manipulation of gut flora. Science 2000; 289:1311-2.
18. Mack DR, Michail S, Wei S, et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276:G941-50.
19. Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289:1352-5.
20. Lyte M. Microbial endocrinology and infectious disease in the 21st century. Trends Microbiol 2004; 12:14-20.
21. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53:108-14.
22. Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126:520-8.
23. Nordin K, Pahlman L, Larsson K, et al. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol 2002; 37:450-7.
24. Yuan YZ, Tao RJ, Xu B, et al. Functional brain imaging in irritable bowel syndrome with rectal balloon-distention by using fMRI. World J Gastroenterol 2003; 9:1356-60.
25. Schwebke JR. Gynecologic consequences of bacterial vaginosis. Obstet Gynecol Clin North Am 2003; 30:685-94.
26. Cadieux P, Burton J, Gardiner G, et al. Lactobacillus strains and vaginal ecology. JAMA 2002; 287:1940-1.
27. Chang TL, Chang CH, Simpson DA, et al. Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc Natl Acad Sci U S A 2003; 100:11672-7.